Inocucor® has assembled an esteemed group of plant scientists and agriculture industry leaders to help guide the company’s R&D and commercialization plans.

ino_scientific_01
ino_scientific_02_ss4

SCIENTIFIC ADVISORY BOARD CHAIR

DR. DONALD L. SMITH

JAMES MCGILL PROFESSOR, MCGILL UNIVERSITY DEPARTMENT OF PLANT SCIENCE, MONTREAL, QUEBEC

CHAIR, INOCUCOR SCIENTIFIC ADVISORY BOARD

Dr. Smith is a well-known researcher and one of the leading experts in the field of plant-microbial interaction. He is the director of the McGill Network for Innovation in Biofuels and Bioproducts (McNIBB). He also currently leads the NSERC funded ($1.2 million per year) Green Crop Network (www.greencropnetwork.com) on crops and climate change, including work on biofuels.

Throughout his research career, work on nitrogen fixation has been a consistent theme, beginning with an undergraduate research project on cyanobacteria in 1974. Current work in this area includes signaling between symbiotic partners during establishment of the legume-rhizobia symbiosis.

During his 30 years at McGill, his research activity has resulted in over 300 publications, nine patents issued and a spin-off company (Bios Agriculture Inc.). Dr. Smith also has been principal investigator on research grants totaling over $45 million, and has been a co-applicant on approximately $12.5 million in other funds. He has had international collaborations with India, China, Brazil, the U.S., the E.U. and Africa.

ino_scientific_03_ss4

DR. JOHN B. ELSTROTT

CHAIRMAN OF MICROBIOME THERAPEUTICS, LLC

CHAIRMAN-WHOLE FOODS MARKET, INC.

SPECIAL ADVISOR TO INOCUCOR’S BOARD

Dr. John B. Elstrott, a high-profile entrepreneur and professor in the natural foods and venture capital worlds, has been appointed special advisor to Inocucor in the areas of sustainability and environmental science, announced Inocucor’s President and CEO Donald R. Marvin.

Among his many business associations, Elstrott serves as Chairman of Whole Foods Market, Inc. and has been a Director of the company since February 1995. He also co-founded and is Chairman of MicroBiome Therapeutics, LLC, a developer of novel non-prescription therapies that target prediabetes and newly diagnosed type 2 diabetes by interacting with the human microbiome. In the academic world, he is a Clinical Professor of Entrepreneurship and the founding Director of the Levy-Rosenblum Institute for Entrepreneurship at Tulane University’s Freeman School of Business.

Elstrott was recently named the 2013 Tulane Distinguished Entrepreneur and Social Entrepreneur of the Year. He is also Co-Founder and Partner Emeritus of Elstrott, Maurer & Hunnewell (EMH Strategy), a boutique strategy-consulting firm based in New Orleans, and a Director of Source Capital Corporation, Traditional Medicinals, Chocolove and NextFoods, Inc.

He holds a Ph.D. from the University of Colorado Boulder, and M.S. and B.S. degrees from Louisiana State University.